Skip to main content

Spire Wealth Management

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1858740 MCLEAN, VA

Position in REGN

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$22,447
-$32,410 QoQ
Shares Held
36
-49.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,173
of 1,322 holders
Holding Since
Mar 2021
22 quarters on record

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Spire Wealth Management holds $7,680,555 across 34 Biotechnology names. REGN ranks #16 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,447 36
2026-03-31 $54,857 71
2025-12-31 $63,293 82
2025-09-30 $51,728 92
2025-06-30 $43,575 83
2025-03-31 $114,161 180
2024-12-31 $112,548 158
2024-09-30 $152,429 145
2024-06-30 $121,919 116
2024-03-31 $171,323 178
2023-12-31 $163,361 186
2023-09-30 $157,185 191
2023-06-30 $6,428,777 8,947
2023-03-31 $7,220,835 8,788
2022-12-31 $107,502 149
2022-09-30 $63,376 92
2022-06-30 $349,357 591
2022-03-31 $482,608 691
2021-12-31 $527,319 835
2021-09-30 $409,101 676
2021-06-30 $128,464 230
2021-03-31 $210,074 444